Shenlian Bio continues share repurchase program
Shanghai Shenlian Biomedical Corporation (SSE:688098) announced the progress of its share repurchase program on May 7, 2025. As of April 30, 2025, the company has cumulatively repurchased 3,417,373 shares, representing 0.8322% of the total share capital. The highest transaction price was CNY 6.29 per share, while the lowest was CNY 5.47 per share. The total expenditure for the repurchase amounted to CNY 20,000,452.13, excluding transaction costs. The repurchase program, approved on November 25, 2024, is intended for employee stock ownership plans, equity incentives, or convertible corporate bonds, with a total repurchase amount ranging from CNY 20,000,000 to CNY 40,000,000 and a price not exceeding CNY 7.86 per share. The company stated it will continue to implement the repurchase plan based on market conditions, in accordance with regulations.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Shanghai Shen Lian Biomedical Corporation publishes news
Free account required • Unsubscribe anytime